School of Medicine
Showing 161-170 of 255 Results
-
Paul Yock, MD
Martha Meier Weiland Professor in the School of Medicine and Professor of Bioengineering, Emeritus
Current Research and Scholarly InterestsHealth technology innovation using the Biodesign process: a systematic approach to the design of biomedical technologies based on detailed clinical and economic needs characterization. New approaches for interdisciplinary training of health technology innovators, including processes for identifying value opportunities in creating new technology-based approaches to health care.
-
Shun Yokoi
Visiting Scholar, Structural Biology
BioShun Yokoi, Ph.D., is a Visiting Scholar in the Department of Structural Biology at Stanford University School of Medicine and a Postdoctoral Researcher at the International Institute for Integrative Sleep Medicine (IIIS) at the University of Tsukuba, Japan. He received his Ph.D. in Physics from Meiji University in 2025.
His research focuses on understanding the relationships between protein structure, dynamics, and function by integrating computational and experimental approaches. His work spans computational and structural biology, with applications in drug discovery and protein engineering. He has investigated a broad range of biological systems, including G protein-coupled receptors (GPCRs), other membrane proteins, enzymes, and fluorescent proteins.
His long-term goal is to use insights into protein structure and dynamics to guide drug discovery and protein engineering. -
Celina Yong, MD, MBA, MSc
Associate Professor of Medicine (Cardiovascular Medicine)
BioCelina Yong, MD, MBA, MSc, FACC, FAHA, FSCAI, is an Associate Professor in the Stanford School of Medicine and Director of Interventional Cardiology at the VA Palo Alto Medical Center. Dr. Yong leads an active health services research lab focused on using large database analyses and novel scalable approaches to improve the quality of cardiovascular care. In her clinical practice, Dr. Yong performs complex percutaneous coronary interventions and transcatheter aortic valve replacements. She is actively involved in clinical trials of novel device and drug therapies for cardiovascular disease. She serves as an Associate Editor for the Journal of the American College of Cardiology and leads the VA-Cardiovascular Trials Consortium.
Prior to joining the Stanford faculty, Dr. Yong completed an MSc in Health Policy, Planning and Financing from the London School of Economics and MBA from Oxford as a Marshall Scholar. She completed her MD at Stanford, internal medicine residency at UCSF, and cardiology and interventional cardiology fellowships at Stanford.